Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Medpace Inc.

    NASDAQ: MEDP · Real-Time Price · USD
    298.42
    -5.58 (-1.84%)
    At close: Jun 13, 2025, 3:59 PM
    297.00
    -0.48%
    After-hours: Jun 13, 2025, 04:39 PM EDT

    Medpace Statistics

    Share Statistics

    Medpace has 28.74M shares outstanding. The number of shares has increased by -1.67% in one year.

    Shares Outstanding

    n/a
    		 28.74M

    Shares Change (YoY)

    n/a
    		 -1.67%

    Shares Change (QoQ)

    n/a
    		 -1.98%

    Owned by Institutions (%)

    n/a
    		 81.88%

    Shares Floating

    n/a
    		 23.32M

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 3.15M, so 10.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.15M

    Short % of Shares Out

    n/a
    		 10.98%

    Short % of Float

    n/a
    		 13.81%

    Short Ratio (days to cover)

    n/a
    		 12.2

    Valuation Ratios

    The PE ratio is 25.43 and the forward PE ratio is 23.09. Medpace's PEG ratio is 0.61.

    PE Ratio

    n/a
    		 25.43

    Forward PE

    n/a
    		 23.09

    PS Ratio

    n/a
    		 4.88

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 12.46

    P/FCF Ratio

    n/a
    		 17.97

    PEG Ratio

    n/a
    		 0.61
    Financial Ratio History

    Enterprise Valuation

    Medpace has an Enterprise Value (EV) of 9.74B.

    EV / Sales

    n/a
    		 4.62

    EV / EBITDA

    n/a
    		 20.46

    EV / EBIT

    n/a
    		 16

    EV / FCF

    n/a
    		 17.02

    Financial Position

    The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 0.93

    Quick Ratio

    n/a
    		 0.93

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 0.27

    Debt / FCF

    n/a
    		 0.22

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 48.98% and Return on Invested Capital is 38.11%.

    Return on Equity

    n/a
    		 48.98%

    Return on Assets

    n/a
    		 19.25%

    Return on Invested Capital

    n/a
    		 38.11%

    Revenue Per Employee

    n/a
    		 $357,466.78

    Profits Per Employee

    n/a
    		 $68,540

    Employee Count

    n/a
    		 5,900

    Asset Turnover

    n/a
    		 1

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 71.54M

    Effective Tax Rate

    n/a
    		 15.03%

    Stock Price Statistics

    The stock price has increased by -24.24% in the last 52 weeks. The beta is 1.48, so Medpace's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 -24.24%

    50-Day Moving Average

    n/a
    		 298.55

    200-Day Moving Average

    n/a
    		 329.13

    Relative Strength Index (RSI)

    n/a
    		 48.4

    Average Volume (20 Days)

    n/a
    		 482,631

    Income Statement

    In the last 12 months, Medpace had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.

    Revenue

    n/a
    		 2.11B

    Gross Profit

    n/a
    		 656.3M

    Operating Income

    n/a
    		 446.87M

    Net Income

    n/a
    		 404.39M

    EBITDA

    n/a
    		 476.12M

    EBIT

    n/a
    		 446.87M

    Earnings Per Share (EPS)

    n/a
    		 13.06
    Full Income Statement

    Balance Sheet

    The company has 669.44M in cash and 126.23M in debt, giving a net cash position of 543.2M.

    Cash & Cash Equivalents

    n/a
    		 669.44M

    Total Debt

    n/a
    		 126.23M

    Net Cash

    n/a
    		 543.2M

    Retained Earnings

    n/a
    		 8.17M

    Total Assets

    n/a
    		 1.9B

    Working Capital

    n/a
    		 -300.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 608.82M and capital expenditures -36.55M, giving a free cash flow of 572.27M.

    Operating Cash Flow

    n/a
    		 608.82M

    Capital Expenditures

    n/a
    		 -36.55M

    Free Cash Flow

    n/a
    		 572.27M

    FCF Per Share

    n/a
    		 18.49
    Full Cash Flow Statement

    Margins

    Gross margin is 31.12%, with operating and profit margins of 21.19% and 19.17%.

    Gross Margin

    n/a
    		 31.12%

    Operating Margin

    n/a
    		 21.19%

    Pretax Margin

    n/a
    		 22.57%

    Profit Margin

    n/a
    		 19.17%

    EBITDA Margin

    n/a
    		 22.58%

    EBIT Margin

    n/a
    		 21.19%

    FCF Margin

    n/a
    		 27.13%

    Dividends & Yields

    MEDP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 3.93%

    FCF Yield

    n/a
    		 5.56%
    Dividend Details

    Analyst Forecast

    The average price target for MEDP is $333, which is 11.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $333

    Price Target Difference

    n/a
    		 11.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $326.5

    Lynch Upside

    n/a
    		 9.41%

    Graham Number

    n/a
    		 88.53

    Graham Upside

    n/a
    		 -70.33%

    Scores

    Altman Z-Score

    n/a
    		 5.67

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist